Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

Completed · Phase 4

Conditions studied: Medical Abortion

In brief

To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.

Key facts

Study ID

NCT02314754

Run by

Gynuity Health Projects

People needed

719

Starts

2014-12-01

Expected to finish

2016-04-01

Last updated by the study team

2016-07-14

Who can join

Age: 11 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• intrauterine pregnancy between 64 days and 77 days' LMP
• eligible for medical abortion according to study doctor assessment
• willing and able to sign consent form
• speak english or spanish (in US sites); speak the local language(s) (in international sites)
• agree to comply with the study procedures and visit schedule

You may not qualify if…

• Have known allergies or present other contraindications to mifepristone or misoprostol

Where it is running

• Hartford GYN Center — Hartford, Connecticut, United States
• Atlanta Women's Center — Atlanta, Georgia, United States
• John H. Stroger, Jr. Hospital of Cook CountY — Chicago, Illinois, United States
• Family Planning Associates Medical Group — Chicago, Illinois, United States
• Scientific Research Institute of Obstetrics and Gynecology — Baku, Azerbaijan
• David Gagua Clinic — Tbilisi, Georgia
• Clínica Comunitaria Santa Catarina — Mexico City, Mexico
• Hung Vuong Hospital — Ho Chi Minh City, Vietnam

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.